HomeCompareRKNEF vs MRK

RKNEF vs MRK: Dividend Comparison 2026

RKNEF yields 1101.81% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RKNEF wins by $1.98M in total portfolio value
10 years
RKNEF
RKNEF
● Live price
1101.81%
Share price
$0.18
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.04M
Annual income
$11,075.78
Full RKNEF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — RKNEF vs MRK

📍 RKNEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRKNEFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RKNEF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RKNEF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RKNEF
Annual income on $10K today (after 15% tax)
$93,653.59/yr
After 10yr DRIP, annual income (after tax)
$9,414.41/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, RKNEF beats the other by $1,086.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RKNEF + MRK for your $10,000?

RKNEF: 50%MRK: 50%
100% MRK50/50100% RKNEF
Portfolio after 10yr
$1.05M
Annual income
$10,436.96/yr
Blended yield
1.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

RKNEF
No analyst data
Altman Z
-9.2
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RKNEF buys
0
MRK buys
0
No recent congressional trades found for RKNEF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRKNEFMRK
Forward yield1101.81%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$2.04M$56.8K
Annual income after 10y$11,075.78$9,798.13
Total dividends collected$1.36M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RKNEF vs MRK ($10,000, DRIP)

YearRKNEF PortfolioRKNEF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$65,790$55,090.35$11,206$366.19+$54.6KRKNEF
2$239,761$169,365.10$12,650$502.35+$227.1KRKNEF
3$544,965$288,420.49$14,407$694.19+$530.6KRKNEF
4$889,451$306,339.09$16,585$967.82+$872.9KRKNEF
5$1,185,350$233,637.48$19,342$1,363.89+$1.17MRKNEF
6$1,413,821$145,496.76$22,913$1,947.19+$1.39MRKNEF
7$1,593,883$81,093.76$27,662$2,823.89+$1.57MRKNEF
8$1,748,175$42,720.42$34,159$4,173.35+$1.71MRKNEF
9$1,892,442$21,895.27$43,337$6,308.80+$1.85MRKNEF
10$2,035,989$11,075.78$56,776$9,798.13+$1.98MRKNEF

RKNEF vs MRK: Complete Analysis 2026

RKNEFStock

Optiva Inc. provides cloud-native monetization and revenue management software to communication service providers (CSP) in Europe, the Middle East, Africa, North America, Latin America, the Caribbean, Asia, and the Pacific Rim. The company's monetization products enable real-time charging, rating, billing, product catalog, policy management, and customer care for any digital services of a CSP. Its solutions include Optiva Charging Engine, a convergent charging solution that helps CSPs to monetize platform; Optiva Business Support System Platform, an end-to-end cloud native converged charging and billing solutions on the private and public cloud; Policy Control, a data monetization for real-time applications, such as video streaming, interactive gaming, and voice over LTE; and Optiva Wholesale Billing, a cloud-based solution that provides converged settlement and accurate interconnect billing. The company also offers Optiva Payment solutions that include various payment methods, including voucher and voucher less payment and top-up solutions. The company was founded in 1999 and is headquartered in Mississauga, Canada.

Full RKNEF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this RKNEF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RKNEF vs SCHDRKNEF vs JEPIRKNEF vs ORKNEF vs KORKNEF vs MAINRKNEF vs JNJRKNEF vs ABBVRKNEF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.